Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers

Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers

A recent report has highlighted a growing trend among cancer patients in Kenya, with an increasing number turning to traditional medicine instead of...

The 3D Urology and Prostate Clinics introduce their groundbreaking 3D Prostate Cancer Targeted Treatment, offering innovative and effective solutions...

Breast cancer is the leading cancer among Indian women, especially in urban regions due to lifestyle shifts. Early detection challenges contribute to...

The first two blood cancer patients in a US-based trial, who had suffered relapses despite having treatment, have now been in remission for up to 120...

While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related...

Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.

The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause of vision loss.

HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...